Name the trial where a Chronicle lead was used for heart failure?
Continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study (ref 3).
What was the conclusion from this trial?
The implantable continuous hemodynamic monitor-guided care did not significantly reduce total heart failure-related events compared with optimal medical management. Additional trials will be necessary to establish the clinical benefit of implantable continuous hemodynamic monitor-guided care in patients with advanced heart failure (ref 3).
Can you name a wireless PA pressure system?
The CardioMEMS HF System (St. Judes) is an FDA-approved heart failure (HF) monitoring wireless system proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients.
Cardiac gated CTA was performed with cardiology opinion.
Identified is a septal hemodynamic monitoring leads in the septal portion of the RVOT. This was the expected position after discussion with cardiologist. This is the first such case we have had with this device. It has since been discontinued by Medtronic and FDA.
The ICD lead is terminating as expected in right ventricular apex.
Wireless devices are implanted into the left lower lobe pulmonary artery.